Madrid calls on health to purchase vaccines against monkeypox to control cases


The region with the highest number of cases (7) has asked Amps to purchase a vaccine to control the monkeypox outbreak. For now, the ministry studies the development of cases before taking a decision.

An image obtained with an electron microscope
An electron microscope image of the 2003 US outbreak provided by the Centers for Disease Control and Prevention.AP

Once again, an infectious outbreak has put the importance of vaccines on the table. In this case, it is about using the smallpox vaccine to try to stop monkeypox outbreaks in several European countries, including Spain. ,It’s about saving vaccines for which there are some indications monkey pox and in which machinery would be necessary to make the dosage“, explains Ames García Rojas, president of the Spanish Association of Vaccinology.

one of the candidates Seems like, According to health sources, this is what creates Bavarian Nordic, A Danish company that has received European Medicines Agency (EMA) approval to market imvanexA vaccine against smallpox in humans, but it has data for use in case of monkeypox infection.

Actually, on Thursday Bavarian Nordic I issued a statement in which I mentioned that There was a pre-sale agreement with a European country. Sources in the pharmaceutical sector have confirmed to this newspaper that it will be sold to Germany.

Barriers to Getting an On-Demand Vaccine That Haven’t Been Manufactured Yet

In response to an email to This Medium, the Danish company, without disclosing the countries, acknowledged that it has received orders to manufacture supplements from several EU states. but The problem is the timing of when these vaccines will be ready. Manufacturing technology is not as agile as that used against covid, mRNA.

here it is made of a vaccine an attenuated virus And that it cannot be multiplied quickly. From the lab they tell the medium it can take weeks to months. The vaccine was approved by the EMA in 2013 and its US counterpart, the FDA, in 2019. It is an indication to prevent the disease in adults 18 years of age and older, who are at high risk of contracting the disease.

In addition, in less than 48 hours, the company received a commission from the US Biomedical Advanced Research and Development Authority (BARDA), part of the State Department’s Office of Preparedness and Response to the Department of Health and Human Services, To manufacture 13 million lyophilized doses in 2023 and 2024, from the existing bulk vaccine, previously purchased by BARDA. This is a first order contract worth $119 million out of a total of $299 million.

Request for vaccines for health from the community of Madrid

In Spain, industry sources assure that the Defense Ministry It has a reserve that could be around the two million doses purchased on the occasion of the Iraq War. and the perceived risks of biological weapons in 2003. García Rojas recalls that “they were then acquired for this reason to protect the troops sent to the Persian Gulf.”

Madrid Community Health Minister Enrique Ruiz Escudero explained early yesterday that “Smallpox vaccine may help prevent“. From the direction of Public Health, Elena Andradas, comments with EL Mundo that she has approached the Spanish Agency for Medicine and Health Products (Amps) to purchase the vaccine.

“The key is how the use is proposed, which be limited in time: When the case is detected Acts as prevention in the first four days of infection The development of the disease, because with the administration of the same the symptoms are avoided in a significant way. if it is done By day 4 to 14, at the latest, clinical symptoms subside”, explains Andradas.

in public health commission Held yesterday, Madrid told other communities about its situation. And the issue of alerts for this new virus was discussed. However, some autonomous women consulted by this newspaper They deny that any intention to make any mass purchases has been a priori communicated Vaccines or antivirals.

Andradas explains that he has requested Health, Amps, to be able to acquire this vaccine, as it is not marketed in Spain. In the United Kingdom it has been used in narrow cases control. ,This is the agency that has to get the batches of this vaccineBecause in the strategic reserve we have about two million, more reactive and not enough”, explains the Madrid director.

for now positive answer not received, Health argues that “at the moment, cases are mild and do not require any other medication other than those available.” Therefore, treatments and vaccines will be acquired as the condition develops, without ruling out any future course of action.

the problem is that “Madrid, for now, focuses on the most critical outbreak, And the vaccine, as we’ve explained to the rest of the communities, would be a useful tool to contain and control outbreaks“Subraya Andradas.

according to the norms of

trust project

know more

About the Author

The co-owner & marketing chief of "The Business News", Sravya is also good at Writing and communicating. she has good networking skills. she is really passionate about publishing quality news articles. - - You can reach Her at Facebook:- @sai.sravya.3910

Leave A Response